Showing posts with label Healthcare. Show all posts
Showing posts with label Healthcare. Show all posts

Tuesday, 20 August 2013

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape

Researchmoz presents this most up-to-date research on"CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China".The report focuses primarily on quantitative marketmetrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

To Read The Complete Report With TOC Kindly Visit: http://www.researchmoz.us/countryfocus-healthcare-regulatory-and-reimbursement-landscape-china-report.html

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalDatas team of industry experts.

China is the most populated country in the world. In 2012, its population was approximately 1.3 billion, approximately one fifth of the global population. Growth has however been effectively controlled and has slowed down due to the strict enforcement of family-planning and one-child policies. The decline in the size of the young working-age group and the growing elderly population are however matters of concern for policy planners. Chinas pharmaceutical industry was estimated to be worth $287 billion in 2012. The market for western medicine was approximately $8.8 billion in 2007 and was estimated at $46.7 billion in 2012. The medical device market was worth approximately $20.1 billion in 2012 and is expected to reach approximately $53.5 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 13.1%.

These positive trends can primarily be attributed to -
  • - Increasingly elderly population
  • - Widening healthcare insurance coverage
  • - Improved Intellectual Property Rights (IPR) environment

Scope
The report provides information on the healthcare, regulatory and reimbursement landscape in China, and includes -
  • - Overview of the pharmaceutical and medical devices markets, comprising market size, segmentation, and key drivers and barriers
  • - Profiles and SWOT analysis of the major players in the pharmaceutical market, of which the major Multinational Companies (MNCs) were GlaxoSmithKline (GSK), Pfizer, and AstraZeneca; and the major domestic players were Harbin Pharmaceutical Group and Tasly Pharmaceutical Group; and the medical device market, of which the major players were Siemens Healthcare, GE Healthcare, Fresenius Medical Care, GlaxoSmithKline, and Philips Healthcare
  • - Insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, regulatory agencies, and market authorization processes for new drugs and medical devices
  • - Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure, and healthcare expenditure
  • - An overview of the opportunities for and challenges to growth in the Chinese healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • - Develop business strategies by understanding the trends shaping and driving Chinas healthcare market
  • - Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments, and companies likely to impact the healthcare market in the future
  • - Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • - Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investments, and strategic partnerships
  • - Identify, understand and capitalize on the opportunities and challenges in Chinas healthcare market  
Contact Us:
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
http://www.researchmoz.us/
www.linkedin.com/company/researchmoz
https://twitter.com/researchmoz
https://www.facebook.com/pages/ResearchMoz/267379433319976
Blog: http://researchmoz.blogspot.com

Thursday, 8 August 2013

Global Parkinson's Disease Market Deep Research Report At Researchmoz

Researchmoz presents this most up-to-date research on"Global Parkinson's Disease Market 2012-2016".The report focuses primarily on quantitative marketmetrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.

View TOC With Detail Report At : http://www.researchmoz.us/global-parkinsons-disease-market-2012-2016-report.html

Analysts forecast the Global Parkinson's Disease market to grow at a CAGR of 1.67 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the aging population. The Global Parkinson’s Disease market has also been witnessing the transition toward using drugs that have new mechanisms of action. However, weak pipeline landscape could pose a challenge to the growth of this market.

Global Parkinson's Disease Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Parkinson's Disease market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space include GlaxoSmithKline plc, Novartis AG, Orion Corp., and Teva Pharmaceuticals Industries Ltd.

The other vendors mentioned in the report are AbbVie Inc., Acadia Pharmaceuticals Inc., Avicena Group Inc., BoehringerIngelheim GmbH, Impax Laboratories Inc., Lundbeck A/S, Newron Pharmaceuticals SpA, Solvay Pharmaceuticals Inc., and Valeant International SRL.

Key questions answered in this report:


  • What will the market size be in 2016 and what will be the growth rate
  • What are key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by key vendors
  • What are the strengths and weaknesses of each of these key vendors

1. Executive Summary

2. List of Abbreviations

3. Introduction

4. Market Research Methodology
Market Research Process
Research Design
Research Methodology

5. Scope of the Report
Market Overview
Product Offerings

6. Market Landscape
6.1 Global Parkinson's Disease Market
Market Size and Forecast
6.2 Market Segmentationby Drug Class
6.3 Five Forces Analysis

7. Geographical Segmentation

8. Key Leading Countries
USA
Germany
Japan

9. Rate of Incidence and Prevalence

10. Vendor Landscape

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

Contact Us:
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
http://www.researchmoz.us/ 
www.linkedin.com/company/researchmoz
https://twitter.com/researchmoz
https://www.facebook.com/pages/ResearchMoz/267379433319976

Blog: http://researchmoz.blogspot.com